Susan Sam,David A Ehrmann
Susan Sam
Polycystic ovary syndrome (PCOS) is a common hormonal disorder that is characterized by hyperandrogenism and menstrual irregularity. Affected women have a high prevalence of insulin resistance and related metabolic complications. The freque...
Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy [0.03%]
GnRH激动剂的冻卵：原理、潜在机制及争议解析
Zeev Blumenfeld
Zeev Blumenfeld
The only clinically accepted method of fertility preservation in young women facing gonadotoxic chemo- and/or radiotherapy for malignant or autoimmune diseases is cryopreservation of embryos or unfertilized ova, whereas cryopreservation of ...
Ovarian Tissue Transplantation: Experience From Germany and Worldwide Efficacy [0.03%]
卵巢组织移植：来自德国及全球的有效性研究
Laura Lotz,Ralf Dittrich,Inge Hoffmann et al.
Laura Lotz et al.
Extraction of ovarian tissue prior to oncologic therapy and subsequent transplantation is being performed increasingly often to preserve fertility in women. The procedure can be performed at any time of the cycle and, therefore, generally d...
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review [0.03%]
促性腺激素释放激素激动剂保护乳腺癌患者卵巢功能机制的进展及相关争议（综述）
Francesca Poggio,Matteo Lambertini,Claudia Bighin et al.
Francesca Poggio et al.
The use of chemotherapy in premenopausal cancer patients may lead to chemotherapy-induced premature ovarian failure. Pharmacological temporary ovarian suppression obtained with the gonadotropin-releasing hormone agonist (GnRHa) administered...
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review [0.03%]
促性腺激素释放激素激动剂在乳腺癌患者卵巢保护潜在机制的述评
Francesca Poggio,Matteo Lambertini,Claudia Bighin et al.
Francesca Poggio et al.
The use of chemotherapy in premenopausal cancer patients may lead to chemotherapy-induced premature ovarian failure. Pharmacological temporary ovarian suppression obtained with the gonadotropin-releasing hormone agonist (GnRHa) administered...
Zeev Blumenfeld
Zeev Blumenfeld
Zeev Blumenfeld
Zeev Blumenfeld
How Will the New Global Polycystic Ovary Syndrome Guideline Change Our Clinical Practice? [0.03%]
新的全球多囊卵巢综合征指南如何改变我们的临床实践？
Susie Jacob,Adam H Balen
Susie Jacob
Polycystic ovary syndrome (PCOS) is a far reaching condition that has a number of reproductive and general health implications. There has been much debate in recent years about the diagnosis and definition of PCOS and a plethora of studies ...
Anti-Müllerian Hormone in Fertility Preservation: Clinical and Therapeutic Applications [0.03%]
抗 Müllerian激素在生育力保存中的临床和治疗应用
Charlotte Sonigo,Isabelle Beau,Nadine Binart et al.
Charlotte Sonigo et al.
Anti-Müllerian hormone (AMH) is a member of the transforming growth factor (TGF)-beta family and a key regulator of sexual differentiation and folliculogenesis. While the serum AMH level has been used in reproductive medicine as a biomarke...
Female Fertility Preservation through Stem Cell-based Ovarian Tissue Reconstitution In Vitro and Ovarian Regeneration In Vivo [0.03%]
基于干细胞的体外卵巢组织重构和体内卵巢再生以实现女性生育力保存
Taichi Akahori,Dori C Woods,Jonathan L Tilly
Taichi Akahori
Historically, approaches designed to offer women diagnosed with cancer the prospects of having a genetically matched child after completion of their cytotoxic treatments focused on the existing oocyte population as the sole resource availab...